Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The California STEM Reporter.
Press releases published on July 31, 2025
Zoom to Release Financial Results for the Second Quarter of Fiscal Year 2026
GlobeNewswire
·
July 31, 2025
SAN JOSE, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- Zoom Communications, Inc. (NASDAQ: ZM) today announced it will release its financial results for the second quarter of fiscal year 2026 on Thursday, August 21, 2025, after the market closes. A live Zoom …
4DMT Presents Positive 60-Week Results from 4D-150 SPECTRA Clinical Trial in DME and Regulatory Update
GlobeNewswire
·
July 31, 2025
4D-150 continues to be well tolerated with no intraocular inflammation observed at any timepoint or dose level 4D-150 demonstrated durable and dose-dependent clinical activity with sustained gains in visual acuity and anatomic control Phase 3 dose (3E10 vg …
iRhythm Technologies Announces Second Quarter 2025 Financial Results
GlobeNewswire
·
July 31, 2025
SAN FRANCISCO, July 31, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the …
GSI Technology, Inc. Announces First Quarter Fiscal 2026 Results
GlobeNewswire
·
July 31, 2025
SUNNYVALE, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- GSI Technology, Inc. (Nasdaq: GSIT) today reported financial results for its first fiscal quarter ended June 30, 2025. Summary Comments for First Quarter Fiscal Year 2026 SRAM revenue increased 7% …
Rackspace Receives SBTi Approval for Net-Zero Targets, Reinforcing Commitment to Sustainable Operations and Innovation
GlobeNewswire
·
July 31, 2025
SAN ANTONIO, July 31, 2025 (GLOBE NEWSWIRE) -- Rackspace Technology® (NASDAQ: RXT), a leading end-to-end hybrid cloud and AI solutions company, announced today that the Science Based Targets Initiative (SBTi) has approved its near-term, long-term, and net- …
Ultragenyx Completes Enrollment of Phase 3 Aspire Study Evaluating GTX-102 for the Treatment of Angelman Syndrome
GlobeNewswire
·
July 31, 2025
Company expects to complete Phase 3 Aspire study in the second half of 2026 Aurora study of GTX-102 in additional ages and genotypes on track to initiate in the second half of 2025 NOVATO, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical …
Sangamo Therapeutics Announces Second Quarter 2025 Earnings Call
GlobeNewswire
·
July 31, 2025
RICHMOND, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company today announced that the company has scheduled the release of its second quarter 2025 financial results after the markets close on …
Orchestra BioMed Announces Proposed Public Offering
GlobeNewswire
·
July 31, 2025
NEW HOPE, Pa., July 31, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, announced …
Monolithic Power Systems Announces Results for the Second Quarter Ended June 30, 2025
GlobeNewswire
·
July 31, 2025
KIRKLAND, Wash., July 31, 2025 (GLOBE NEWSWIRE) -- Monolithic Power Systems, Inc. (“MPS”) (Nasdaq: MPWR), a fabless global company that provides high-performance, semiconductor-based power electronics solutions, today announced financial results for the …
Monolithic Power Systems Provides Earnings Commentary for the Quarter Ended June 30, 2025
GlobeNewswire
·
July 31, 2025
KIRKLAND, Wash., July 31, 2025 (GLOBE NEWSWIRE) -- MPS will report its results after the market closes on July 31, 2025 and host a question-and-answer webinar at 2:00 p.m. PT / 5:00 p.m. ET. The live event will be held via a Zoom webcast, which can be …
Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed
GlobeNewswire
·
July 31, 2025
• Ligand to invest $35 million in exchange for a tiered royalty on future sales of Orchestra’s AVIM therapy and Virtue SAB and an additional $5 million in an equity private placement • Medtronic to invest $10 million in an equity private placement and an …
Ascendis Pharma to Report Second Quarter 2025 Financial Results and Provide Business Update on August 7, 2025
GlobeNewswire
·
July 31, 2025
COPENHAGEN, Denmark, July 31, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it will report second quarter 2025 financial results and provide a business update on Thursday, August 7, 2025, after the close of the U.S. financial …
Asure Announces Second Quarter 2025 Results
GlobeNewswire
·
July 31, 2025
Second Quarter 2025 Total Revenues Increased 7% to $30.1 million Recurring Revenues Grew 6% from Prior Year AUSTIN, Texas, July 31, 2025 (GLOBE NEWSWIRE) -- Asure Software, Inc. (“we”, “us”, “our”, “Asure” or the “Company”) (Nasdaq: ASUR), a leading …
scPharmaceuticals to Announce Second Quarter 2025 Financial Results After the Market Close on August 7, 2025
GlobeNewswire
·
July 31, 2025
BURLINGTON, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through patient-centric innovations, today announced that scPharmaceuticals management …
Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2025 Financial Results on August 7, 2025
GlobeNewswire
·
July 31, 2025
SOUTH SAN FRANCISCO, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that the company will host a conference call and webcast on August 7, 2025 at 4:30 pm ET …
Ruanyun Edai Technology Announces Financial Results for Fiscal Year 2025
GlobeNewswire
·
July 31, 2025
NANCHANG, China, July 31, 2025 (GLOBE NEWSWIRE) -- Ruanyun Edai Technology Inc. (“Ruanyun” or the “Company”) (NASDAQ: RYET), a leading AI-powered education technology company in China, today announced its financial results for the fiscal year ended March …
Bilan semestriel du contrat de liquidité de la société Inventiva conclu avec Kepler Cheuvreux
GlobeNewswire
·
July 31, 2025
Daix (France), New York (New York, Etats-Unis), le 31 juillet 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (la "Société"), société biopharmaceutique spécialisée dans le développement clinique de petites molécules administrées par voie orale pour le …
Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux
GlobeNewswire
·
July 31, 2025
Daix (France), New York (New York, United States), July 31, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the …
Nephros Schedules Second Quarter 2025 Financial Results Conference Call
GlobeNewswire
·
July 31, 2025
SOUTH ORANGE, N.J., July 31, 2025 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its second-quarter financial …
ZenaDrone de ZenaTech inicia la actualización de su membresía en AUVSI, lo que permite el liderazgo en la política de drones y fortalece la colaboración con el sector de defensa y el gobierno de EE.UU.
GlobeNewswire
·
July 31, 2025
VANCOUVER, British Columbia, July 31, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), un proveedor de soluciones de tecnología empresarial especializado en drones con IA (Inteligencia Artificial), Dron como un …